DexCom (NASDAQ:DXCM) Rating Increased to Buy at StockNews.co

StockNews.com upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research report released on Wednesday. Several other analysts also recently weighed in on the company. Canaccord Genuity Group lifted their target price on DexCom from $144.00 to $145.00 and gave the stock a buy rating in […]

Related Keywords

United States , Canada , Raymond James , Michael Jon Brown , Jeremem Sylvain , Nasdaq , Blair William Co , Sands Capital Management , Canaccord Genuity Group , Citigroup , Capital Research Global Investors , Securities Exchange Commission , Royal Bank , Dexcom Inc , Artisan Partners Limited Partnership , Free Report , Genuity Group , Moderate Buy , Get Free Report , Exchange Commission , Jon Brown , Research Global Investors , Capital Management , World Investors , Partners Limited Partnership , Blair William , Dexcom Share , Dexcom Real Time , Dexcom Daily , Dexcom , Nasdaq Dxcm , Dxcm , Medical , 25213110 , Upgrade , Stocknews Com ,